GB202312455D0 - A vaccine for the treatment or prevention of Burkholderia species infection in a subject. - Google Patents

A vaccine for the treatment or prevention of Burkholderia species infection in a subject.

Info

Publication number
GB202312455D0
GB202312455D0 GBGB2312455.5A GB202312455A GB202312455D0 GB 202312455 D0 GB202312455 D0 GB 202312455D0 GB 202312455 A GB202312455 A GB 202312455A GB 202312455 D0 GB202312455 D0 GB 202312455D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
prevention
subject
treatment
burkholderia species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2312455.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College Dublin
Original Assignee
University College Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College Dublin filed Critical University College Dublin
Priority to GBGB2312455.5A priority Critical patent/GB202312455D0/en
Publication of GB202312455D0 publication Critical patent/GB202312455D0/en
Pending legal-status Critical Current

Links

GBGB2312455.5A 2023-08-15 2023-08-15 A vaccine for the treatment or prevention of Burkholderia species infection in a subject. Pending GB202312455D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2312455.5A GB202312455D0 (en) 2023-08-15 2023-08-15 A vaccine for the treatment or prevention of Burkholderia species infection in a subject.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2312455.5A GB202312455D0 (en) 2023-08-15 2023-08-15 A vaccine for the treatment or prevention of Burkholderia species infection in a subject.

Publications (1)

Publication Number Publication Date
GB202312455D0 true GB202312455D0 (en) 2023-09-27

Family

ID=88093321

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2312455.5A Pending GB202312455D0 (en) 2023-08-15 2023-08-15 A vaccine for the treatment or prevention of Burkholderia species infection in a subject.

Country Status (1)

Country Link
GB (1) GB202312455D0 (en)

Similar Documents

Publication Publication Date Title
MX2022011671A (en) Coronavirus vaccines and methods of use.
MX2019009443A (en) Methods of treating influenza.
MX2017008720A (en) Derivatives and methods of treating hepatitis b infections.
PH12016501379A1 (en) Azepane derivatives and methods of treating hepatitis b infections
MX2021007602A (en) Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infections.
EP2081593A4 (en) Live bacterial vaccines for viral infection prophylaxis or treatment
EP4143207A4 (en) Vaccine composition for preventing or treating infection of sars-cov-2
TW200731986A (en) Use of vaccines for the treatment/prevention of the transmission of pathogens
PH12018502297A1 (en) 9-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (uti) treatment
IL287099A (en) A subunit vaccine for treatment or prevention of a respiratory tract infection
WO2016086153A3 (en) Use of hsp90 inhibitors for the treatment of hiv infections and aids
EP4093873A4 (en) Methods, compositions, and vaccines for treating a virus infection
HUE058250T2 (en) Medicament for prevention or treatment of rhinovirus infection
MY172788A (en) Influenza vaccines
WO2007107748A3 (en) Inhibition of tumour growth
GB202312455D0 (en) A vaccine for the treatment or prevention of Burkholderia species infection in a subject.
WO2010138419A3 (en) Materials and methods for treating viral infections
MX2022001261A (en) Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseases.
EP4238983A4 (en) Vaccine composition for prevention or treatment of sars-coronavirus-2 infection
WO2020025657A9 (en) Composition for use in the prevention and/or treatment of the genitourinary mucosa
MX2023009041A (en) Use of proteasome inhibitors in the treatment of coronavirus infections.
GB202015584D0 (en) Treatment for viral infection
MX2022001266A (en) Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseases.
MX2022000663A (en) Pharmaceutical formulations containing gaboxadol for therapeutic treatment.
SG10201907677QA (en) Formulations for use in the prevention and/or treatment of peripheral neuropathy and its associated diseases.